Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olesya I Zorina

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Parkinsonism & Related Disorders|July 1, 2008
Trace amine associated receptor 1 and movement controlTatyana D Sotnikova, Olesya I Zorina, Valentina Ghisi, et al.
Drug Safety|March 16, 2013
Comparative performance of two drug interaction screening programmes analysing a cross-sectional prescription dataset of 84,625 psychiatric inpatientsOlesya I Zorina, Patrick Haueis, Waldemar Greil, et al.
Pharmacoepidemiology and Drug Safety|July 21, 2011
Evaluation of drug interactions and dosing in 484 neurological inpatients using clinical decision support software and an extended operational interaction classification system (Zurich Interaction System)Markus Guzek, Olesya I Zorina, Alexander Semmler, et al.
Pharmacoepidemiology and Drug Safety|April 21, 2012
Comparative evaluation of the drug interaction screening programs MediQ and ID PHARMA CHECK in neurological inpatientsOlesya I Zorina, Patrick Haueis, Alexander Semmler, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Parkinsonism & Related Disorders|July 1, 2008
Trace amine associated receptor 1 and movement controlTatyana D Sotnikova, Olesya I Zorina, Valentina Ghisi, et al.
Drug Safety|March 16, 2013
Comparative performance of two drug interaction screening programmes analysing a cross-sectional prescription dataset of 84,625 psychiatric inpatientsOlesya I Zorina, Patrick Haueis, Waldemar Greil, et al.
Pharmacoepidemiology and Drug Safety|July 21, 2011
Evaluation of drug interactions and dosing in 484 neurological inpatients using clinical decision support software and an extended operational interaction classification system (Zurich Interaction System)Markus Guzek, Olesya I Zorina, Alexander Semmler, et al.
Pharmacoepidemiology and Drug Safety|April 21, 2012
Comparative evaluation of the drug interaction screening programs MediQ and ID PHARMA CHECK in neurological inpatientsOlesya I Zorina, Patrick Haueis, Alexander Semmler, et al.
Pageof 1